Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction : Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) - 21/08/11

Elliott M. Antman, MD ^a, ⁎ , David A. Morrow, MD ^a, Carolyn H. McCabe, BS ^a, Frank Jiang, MD, PhD ^b, Harvey D. White, Dsc ^c, Keith A.A. Fox, MBChB ^d, Divakar Sharma, PhD ^b, Paul Chew, MD ^b, Eugene Braunwald, MD ^a

for the ExTRACT-TIMI 25 Investigators

^a TIMI Study Group, Boston, Mass 

^b Aventis Pharmaceuticals, Inc, Bridgewater, NJ 

^c Green Lane Hospital, Auckland, New Zealand 

^d University and the Royal Infirmary of Edinburgh, Edinburgh, Scotland 

Reprint requests: Elliott M. Antman, MD, TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115.